Caitlin Raymond: Augmented Intelligence Enhancing Human Capability Without Replacement
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at University of Wisconsin-Madison, shared a post on LinkedIn:
“The AI in medicine discourse has two settings: it’s going to replace physicians, or it’s too dangerous to touch.
Both arguments imagine AI as an autonomous agent.
That’s not how I use it, and I don’t think it’s how physicians should.
There’s a better frame: augmented intelligence.
- The AI amplifies your thinking, drafting, and analysis
- You retain intellectual ownership of the output
- You direct the work, evaluate what comes back, and correct what’s wrong
- Accountability never leaves the physician
In practice, I use Claude for writing and coding – drafting posts, structuring arguments, generating diagrams.
I use Gemini for assistant tasks.
In every case, I’m directing the work and evaluating the output critically before anything goes anywhere.
The post that goes up is mine.
The thinking is mine.
The AI accelerated production of a written artifact that represents my analysis.
It did not perform the analysis.
Anyone in laboratory medicine already understands the oversight principle intuitively.
We don’t report analyzer results without understanding what the analyzer did.
We run QC.
We investigate flags.
AI output requires the same scrutiny — because the distinctive failure mode of these tools isn’t garbled output. It’s fluent, confident, plausible-sounding output that is wrong.
And on opting out: physicians who wait aren’t avoiding risk.
They’re outsourcing the learning curve.
Someone will set the norms for how AI gets used in your institution and your specialty.
Better that it’s clinicians with hands-on experience than administrators and vendors who don’t see patients.
Augmented intelligence, done right, is not about ceding judgment to a machine.
It’s about using a powerful tool with the same rigor we bring to every other tool in medicine.
Full post in the first comment.”
Other posts featuring Caitlin Raymond on Hemostasis Today.
-
May 18, 2026, 16:35Abdurrahmaan Ali Suei Elbuzidi: What is the Optimal Anticoagulation Monitoring Target in ECMO?
-
May 18, 2026, 16:34Serah N. Gathu: Gaining Valuable Updates on ACS Management at the Africa STEMI Conference
-
May 18, 2026, 16:34Mahmoud Alhariri: Apixaban in Hemodialysis-Treated Kidney Failure With Newly Diagnosed AF
-
May 18, 2026, 16:33Dimitrios Kontothanassis: The Role of Thermal Ablation in GSV Reflux Treatment – LIVE 2026
-
May 18, 2026, 16:32Michael Lichardi: New Publication on Complex Anticoagulation Management in Critical Care
-
May 18, 2026, 16:28Reza Shojaei: The Global Plasma-to-Ig Supply Chain
-
May 18, 2026, 16:01Abdul Mannan: The Hardest Conversations in Myelofibrosis
-
May 18, 2026, 15:57Bridging Innovation and Access at the WFH 2026 World Congress – South African Haemophilia Foundation
-
May 18, 2026, 15:55Pierre François Sabouret: Network Meta-Analysis of Antithrombotic Therapy in Ischemic Stroke Patients